Leddon JL, Gulati S, Haque S, Allen C, et al. Phase 2 trial of adjuvant nivolumab following salvage resection in patients with recurrent squamous cell carcinoma of the head and neck. Clin Cancer Res 2022 Jun 2. pii: 699312. doi: 10.1158/1078-0432.CCR-21-4554.
PMID: 35653116